Key financial ranges
Market cap · USD equivalent−∞—+∞
P/E ratio−∞—+∞
Annual revenue · USD equivalent−∞—+∞
Revenue growth−∞—+∞
2,041–2,060 of 6,553
CompanyMarket capP/ERevenueRev. growthNet incomeCashDebtAI value
CABOCable One, Inc.$140.54M—$1.5B-4.9%-$356.46M$166.19M$3.07BAI pending
BHAVBHAV Acquisition Corp$140.75M————$692.7K—AI pending
RGPResources Connection, Inc.$141.22M—$452.01M-18.0%-$40.6M$82.37M$22.52MAI pending
PLUNPlutonian Acquisition Corp. II$141.7M————$492.56K$0AI pending
TRAKReposiTrak, Inc.$142.12M20.8×$22.61M+10.5%$6.98M$26.41M$114.94KAI pending
BNCCEA Industries Inc.$142.26M—$26.41M+2,177.6%$115.25M$3.06M$3.61MAI pending
BOOMDMC Global Inc.$142.55M—$609.84M-5.1%-$13.45M$28.55M$104.2MAI pending
EQEquillium, Inc.$142.67M—$41.1M+13.9%-$8.07M$57.16M$584KAI pending
UNCYUnicycive Therapeutics, Inc.$142.9M—$675K-29.0%-$30.54M$44.19M$671KAI pending
LXLexinFintech Holdings Ltd.$143.31M1.0×$1.88B-3.3%$239.82M$308.32M$80.94MAI pending
FMBMF&M Bank Corp$143.47M9.9×$52.7M+17.9%$11.23M$60.75M$10.99MAI pending
PALProficient Auto Logistics, Inc$143.49M————$8.13M$75.7MAI pending
OKUROnKure Therapeutics, Inc.$143.56M—$0—-$52.67M$166.5M$926KAI pending
INOInovio Pharmaceuticals, Inc.$143.72M—$65.34K-70.0%-$84.95M$31.53M$8MAI pending
OXSQOxford Square Capital Corp.$144.87M—$40.34M-5.5%-$18.73M$34.61M—AI pending
INGNInogen Inc$145.03M—$295.3M+5.9%-$22.75M$87.28M$15.79MAI pending
MYXMaywood Acquisition Corp. 2$145.16M191.0×———$307.16K—AI pending
CLARClarus Corp$145.3M—$250.44M-5.2%-$46.56M$28.93M$17.15MAI pending
ZJKZJK Industrial Co., Ltd.$145.37M14.1×$56.1M+48.4%$10.15M$14.35M$3.6MAI pending
SRBKSR Bancorp, Inc.$145.4M45.1×$14.96M+12.9%$1.55M$63.68M$53MAI pending